Search results
J&J's phase 2 Sjögren's data support FcRn strategy in the autoimmune disorder
FierceBiotech· 6 days agoThe DAHLIAS study enrolled 163 patients with the autoimmune disease who received either a 5-mg/kg or...
Why Diabetes, High Blood Pressure and More Conditions Can Make Heatwaves Dangerous
CNET· 16 hours agoA heat wave has stifled parts of the US this week, with people across the Midwest and Northeast...
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome...
Lodi News-Sentinel· 6 days agoKyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune
The nervous system disorder that's being linked to long COVID now
MSN News· 3 days agoGuava Health explains the complex post-pandemic relationship between Long COVID and postural...
Cartesian Therapeutics (NASDAQ:RNAC) Given Buy Rating at HC Wainwright
ETF DAILY NEWS· 5 days agoHC Wainwright reiterated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Monday morning, Benzinga reports. They currently have a $54.00 ...
Key driver of inflammatory bowel disease identified
Nature· 2 days agoIn-depth analysis of a suspect genomic region revealed a key driver of IBD and other autoimmune conditions — as well as druggable targets.
Early Signs of Lupus in Females
Verywell Health via Yahoo News· 5 days agoAn early sign of lupus that females report is fatigue. However, because lupus affects multiple organ systems, it can be hard to tell. Find answers here.
Progentec Diagnostics Announces Appointment of Immunology Expert Dr. Bernard Rubin
Brenham Banner-Press· 6 days agoProgentec Diagnostics, a leader in diagnostic and digital technologies for management of autoimmune diseases, announced today that Bernard R. Rubin, DO, ...
Scientists Uncover Links Between MS and Epstein-Barr Virus | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 4 days agoThe discovery that the Epstein-Barr virus might be a major driver of multiple sclerosis has...
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Buy” by Analysts
ETF DAILY NEWS· 8 hours agoShares of Xencor, Inc. (NASDAQ:XNCR – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are presently covering the stock, MarketBeat.com reports ...